Bluejay Diagnostics, Inc. BJDX 深 沪
已收盘 12-19 16:00:00 美东时间
0.8018
-0.082
-9.28%
华盛通- 最 高1.45
- 今 开0.87
- 成交量 15.03万股
- 最 低 0.7759
- 昨 收 0.8838
- 总市值 1615.72万
- 52周最高 10.20
- 市盈率 静 --
- 换手率 0.75%
- 52周最低 0.7759
- 委 比 -99.60%
- 总股本 2015.12万
- 历史最高 13.9799
- 量 比 1.93
- 振 幅 76.27%
- 历史最低 0.0652
- 每 手 1
- 风险率 1.09%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Bluejay Diagnostics Provides Mid-Year Business and Corporate Update
Bluejay Diagnostics provides a mid-year update, highlighting advancements in its SYMON-II clinical trial for its Symphony IL-6 test, aiming to predict sepsis mortality. The company plans a 510(k) FDA submission by Q4 2027 and approval by Q3 2028. It is also working on manufacturing improvements and seeking $30 million in financing. The company has reduced its workforce to conserve cash and announced its 2025 Annual Meeting for stockholder approvals.
06-03 20:05
Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Shares of Zhibao Technology Inc. (NASDAQ:ZBAO) rose sharply in today's pre-market trading after the company announced that it has won a tender to provide high-end medical third party administration services to the People’s Insurance Company of China Limited. Zhibao Technology shares jumped 18.8% to ...
2024-09-03 17:13
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Conduit Pharmaceuticals (NASDAQ:CDT) stock increased by 27.4% to $0.16 during Monday's after-market session. The company's market cap stands at $15.0 million. TNF Pharmaceuticals (NASDAQ:TNFA) stock moved upwards by 18.82% to $2.02. The market value of their outstanding shares is at $4.7 mil...
2024-09-03 04:31
